Earlier this month, the FDA gave its recommendations to Congress for the next reauthorization of the Prescription Drug User Fee program. In order to support these changes, the FDA recommends that the annual user fee collections be increased $87.4 million to $392.8 million. The Prescription Drug User Fee Act (PDUFA) of November 1992 first authorized […]
Pay Invoice
Latest Blogs
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.